Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Invested Capital (2020 - 2025)

Historic Invested Capital for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $437.7 million.

  • Agilon Health's Invested Capital fell 3162.07% to $437.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $437.7 million, marking a year-over-year decrease of 3162.07%. This contributed to the annual value of $536.2 million for FY2024, which is 2344.39% down from last year.
  • Agilon Health's Invested Capital amounted to $437.7 million in Q3 2025, which was down 3162.07% from $540.5 million recorded in Q2 2025.
  • Agilon Health's Invested Capital's 5-year high stood at $1.2 billion during Q2 2021, with a 5-year trough of -$298.2 million in Q1 2021.
  • For the 5-year period, Agilon Health's Invested Capital averaged around $812.0 million, with its median value being $912.4 million (2023).
  • Per our database at Business Quant, Agilon Health's Invested Capital skyrocketed by 48939.97% in 2021 and then tumbled by 3306.01% in 2023.
  • Quarter analysis of 5 years shows Agilon Health's Invested Capital stood at $1.1 billion in 2021, then fell by 4.62% to $1.0 billion in 2022, then tumbled by 33.06% to $700.3 million in 2023, then dropped by 23.44% to $536.2 million in 2024, then fell by 18.37% to $437.7 million in 2025.
  • Its Invested Capital was $437.7 million in Q3 2025, compared to $540.5 million in Q2 2025 and $631.9 million in Q1 2025.